Literature DB >> 17426671

Pathophysiology of involuntary emotional expression disorder.

Peter V Rabins1, David B Arciniegas.   

Abstract

Extensive clinical experience and research suggest that a cortico-limbic-subcortico-thalamic-ponto-cerebellar network plays a significant role in the expression of human emotions. This network includes specific cerebral, cerebellar, and brainstem areas and their multiple projections/pathways, with activity modulated through serotonergic, dopaminergic, glutamatergic, and possibly sigma receptor neurotransmitter systems. Disruptions of regulatory and inhibitory mechanisms in the structure and function of this network likely constitute a pathophysiological basis for the crying and laughing episodes characteristic of involuntary emotional expression disorder. Pharmacologic interventions targeting the neurochemical modulators of the emotional expression systems may afford opportunities for symptom control among persons affected by this disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426671     DOI: 10.1017/s1092852900025979

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  8 in total

Review 1.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 2.  The neurobiology of human crying.

Authors:  Lauren M Bylsma; Asmir Gračanin; Ad J J M Vingerhoets
Journal:  Clin Auton Res       Date:  2018-04-23       Impact factor: 4.435

Review 3.  Dextromethorphan/quinidine: in pseudobulbar affect.

Authors:  Karly P Garnock-Jones
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

4.  Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review.

Authors:  Amelia J Hicks; Fiona J Clay; Jennie L Ponsford; Luke A Perry; Mahesh Jayaram; Rachel Batty; Malcolm Hopwood
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

5.  Variability in depressive symptoms predicts cognitive decline in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; Benjamin E Leiby
Journal:  Am J Geriatr Psychiatry       Date:  2009-07       Impact factor: 4.105

6.  Psychiatric disorders and traumatic brain injury.

Authors:  Marcelo Schwarzbold; Alexandre Diaz; Evandro Tostes Martins; Armanda Rufino; Lúcia Nazareth Amante; Maria Emília Thais; João Quevedo; Alexandre Hohl; Marcelo Neves Linhares; Roger Walz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

Review 7.  Diagnosing pseudobulbar affect in traumatic brain injury.

Authors:  William Engelman; Flora M Hammond; James F Malec
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-07       Impact factor: 2.570

Review 8.  Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms.

Authors:  Jong S Kim
Journal:  J Stroke       Date:  2016-09-30       Impact factor: 6.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.